One major problem in cancer therapy is the immortality of tumor cells showing an active telomerase, which is responsible for the elongation of the telomeres after each cellular division and the knocking down of apoptotic suppressors. A further phenomenon occurring during cancer therapies is the problem of multicellular resistance. To develop therapeutic anticancer approaches inducing cellular apoptosis, gene-modified biological in vitro systems were established and evaluated for drug screening in a capillary system for a real-time, impedimertic monitoring. Multicellular spheroids of the human breast cancer cell line T-47D clone 11 were transfected with 1) antisense caspase-3 cDNA expression vectors for knocking down the main cell death molecule and 2) sense Bcl-xl cDNA expression vectors for overexpressing the apoptotic suppressor, resulting in more aggressive tumor models. These gene-modified tumor spheroids less sensitive for apoptosis were developed for screening drugs such as methotrexate in tumor spheroid-based biosensor systems via impedance spectroscopy. In this report, it is demonstrated that this could successfully exhibit that this real-time monitoring system with tumor spheroids positioned in a capillary system with a 4-electrode configuration is the most efficient high-content screening module for impedimetric measurements of physiological alterations during gene modification and drug application. (Journal of Biomolecular Screening 2005:705-714)
INTRODUCTION
M ULTICELLULAR REAGGREGATES of tumor cells have widely been used as potential test models in different fields of cancer research including pharmacology, radiology, and chemotherapy. [1] [2] [3] [4] [5] [6] The advantage of using 3-dimensional (3D) cell cultures in vitro is that they preserve biochemical and morphological characteristics similar to in vivo tissues, for example, cell-cell and cellextracellular matrix interactions as well as self-organization, which enables studies on biological mechanisms such as prolifera-tion, differentiation, and programmed cell death. Especially for therapeutically orientated screening studies such as discovering new drugs and testing drugs and their mechanisms, novel tumor spheres as tissue models are of interest. Also, the combination of such 3D in vitro tumor models with powerful electronic technologies concerning drug development for diagnosis and therapy is required. In recent studies, the development of a biosensor using multicellular tumor spheroids as recognition element was discussed. In these reports, spheroids were bioelectronically characterized by measuring impedance with respect to physiological alterations after toxicological treatment. [7] [8] [9] It was demonstrated that 3D in vitro breast cancer spheroids could mimic the in vivo micromilieu of small initial avascular tumors. They consist of a necrotic core surrounded by an area of highly proliferative tumor cells representing the periphery of the spheroid near to quiescent and viable cells close to the necrotic center. 4, 5, 10, 11 Another important issue is that cancer cells that are grown as spheroids exhibit characteristics of multicellular resis-tance as it is present in patient tumors. Mechanisms of multicellular resistance can be classified into contact resistance and resistance inherent in the spheroid structure including, for example, inhibition of apoptosis, modulation of protein expression, and permeability problems. 2, 12 A comparison of protein expression profiles between monolayers and spheroids of human colorectal cancer cells showed subtle differences that affect important intracellular signal transduction systems and thus influence multiple cellular functions. 13 It has been reported that mechanisms of resistance induced in vivo might not be observed in cells in vitro that are cultured as monolayers. 14 Hence, another important mechanism occurring in tumor cells cultured as 3D cell aggregates is multidrug resistance (MDR), which seems to be analogous to the physiological resistance observed in tumors in vivo. Incubation of multicellular spheroids with drugs resulted in an induction of resistance and export of the applied and penetrated drugs, whereas the same cells cultured as monolayers showed no MDR. 15 In a further study, it was demonstrated that rat hepatocyte spheroids were less sensitive to methotrexate (MTX) exposure than monolayers of the same cells. 16 MTX belongs to the group of antimetabolites and is used to treat different kinds of cancer (e.g., breast cancer). 17, 18 The cytotoxic effect of MTX emerges from inhibition of the dihydrofolate reductase that is necessary for the biosynthesis of DNA and RNA. MTX is known to induce apoptosis in different cells. [19] [20] [21] The basis of apoptotic mechanisms is the interaction of special signal pathways induced by various stimuli. One major effector of apoptosis is caspase-3 (CPP32), a cystein protease that exists in cells as an inactive precursor that can be activated by proteolytic processing. Activated caspases are able to cleave substrates, which finally results in apoptosis. In contrast, proteins of the Bcl-2 family can suppress apoptosis. It was reported that Bcl-2 and related proteins were involved in preventing apoptosis in spheroids of human osteosarcoma cells exposed to ionizing radiation. 1 Several reports describe that these proteins inhibit cell death induced by different stimuli and suggest that they exert their antiapoptotic action at the processing of certain caspases (e.g., caspase-3) to their active forms. [22] [23] [24] Here, we created multicellular spheroids of human breast cancer cells (T-47D clone 11) as an in vitro model to study the effects of suppressing caspase-3 via an antisense strategy and of overexpressing Bcl-xl, a member of the Bcl-2 suppressor family, on apoptotic signaling in the cells of the spheroids. These transfected tumor spheroids, more aggressive because of 1) the Bcl-xldirected apoptotic suppression and 2) knocking down the cell death molecule caspase-3, were then treated with MTX to investigate whether the cytotoxic effect of the agent is influenced and whether it could be improved during cancer treatment via a combinatorial therapeutic approach. A further aim of this study was to demonstrate the characterization of the gene-modified tumor models and MTX-treated tumor spheroids, positioned in a capillary biosensor system, via impedance spectroscopy according to morphological and physiological changes in real time and omitting any labeling.
MATERIALS AND METHODS

Cultivation of tumor spheroids
Human breast carcinoma cells T-47D clone 11 were cultured as a monolayer in RPMI 1640 medium (10% FCS 50 U/ml penicillin, 50 µg/ml streptomycin) until confluent growth. Cells were harvested by trypsination and counted with a multisizer II (Beckman Coulter, Fullerton, CA) for determination of the cell concentration. A total of 3 × 10 6 to 7 × 10 6 cells were transferred into a spinner flask (125 ml culture medium) and aggregated at 37°C, 7.5% CO 2 on a magnetic shaker at 75 rpm for 10 days, whereas 300 to 400 spheroids could be generated. The morphology of the spheroids was very uniform, and the size in this stage varied between 300 and 400 µm in diameter. For further experiments, tumor spheroids were transferred to cell culture dishes (35 mm) and cultivated on a gyratory shaker at 90 rpm until usage.
MTX treatment of tumor spheroids
To find an MTX dose that significantly induces cellular apoptosis, different concentrations of MTX (1, 10, 20, 100 µM) were applied on tumor spheroids cultivated in cell culture dishes for 24 h. The expression of the apoptotic effector enzyme caspase-3 was measured because of apoptotic activity in the cells of the spheroids.
Preparation of frozen sections of tumor spheroids
The tumor spheroids were collected in Eppendorf tubes, washed twice in phosphate-buffered saline (PBS), and fixed in 4% formaldehyde/PBS for 30 min at room temperature (RT). After 2 washes in PBS, the tumor spheres were transferred into 25% sucrose/PBS overnight. Frozen sections were cut in a depth of 7 to 10 µm on a cryostat (Leica, Nussloch, Germany). The sections were placed on gelatinized cover slides and stored in a freezer.
Microscopy
Immunochemically stained cryosections of tumor spheroids were documented using a Zeiss Axiophot II microscope with DIC-Nomarski and fluorescence optics. Whole mounts of viable spheroids were examined with an Olympus IMT-2 inverted microscope with transmission illumination.
Polyacrylamide gel electrophoresis and protein transfer
For detection of caspase-3, a 1-dimensional polyacrylamide gel electrophoresis was performed in the presence of sodium dodecyl sulfate (SDS) according to the protocol of Laemmli. 25 The resolving gel contained 12% acrylamide, and the proteins were identified by immunoblotting. As a molecular weight (M r ), standard protein color markers (wide range; Sigma-Aldrich, Deisenhofen, Germany) were used. Immunoblotting was carried out by semidry electroblotting the proteins from SDS-polyacrylamyide gels (20- 50 µg protein/lane) onto a nitrocellulose membrane (Hybond C; Amersham Buchler, Braunschweig, Germany). The nitrocellulose membranes were blocked in 5% nonfat dry milk/TBST (0.5 M Tris-HCl, pH 8.0; 150 mM NaCl; 0.075% Tween 20) and then washed 3 times at RT with TBST for 10 min. The filters were incubated with a 1:500 dilution of anti-caspase-3 (Sigma-Aldrich, Deisenhofen, Germany) for 1.5 h at RT. The membranes were washed 3 times with TBST at RT for 10 min and incubated with peroxidase-conjugated goat antirabbit IgG (Dianova, Hamburg, Germany) for 1 h at RT. The complexes were visualized using TMB-stabilized substrate for horseradish peroxidase (Promega, Mannheim, Germany). The membranes were scanned, and the density of the different protein bands was determined using a densitometer (GS-710; Bio-rad, Hercules, CA).
Determination of the protein concentration
Protein concentrations were measured according to the method of Bradford, 26 and bovine serum albumin was used as a standard.
Preparation of tumor spheroid protein extracts
Tumor spheroids were collected from the cell culture dishes (35 mm 
Detection of apoptotic cells in tumor spheroids
Apoptotic cells were visualized by histochemical detection of nucleosomal fragmentation products (TUNEL) applying the in situ Cell Detection Kit (Roche Diagnostics GmbH, Mannheim, Germany). The procedure was carried out following the manufacturer's instructions. In brief, paraformaldehyde-fixed cryosections of spheroids were permeabilized in 0.1% Triton X-100/PBS for 2 min on ice (4°C), and nucleosomal fragmentation products were detected by 3′-end labeling with fluorescein-dUTP using terminal deoxynucleotidyl transferase (60 min at 37°C in a humified chamber in the dark). The slides were imbedded and DAPI-stained with Vectashield Mounting Medium (Vector Laboratories, Burlingame, CA). For prolonged storage, the cover slides were sealed around the perimeter with nail polish. For quantification of apoptosis, positively stained cells of 5 cryosections were counted in relation to the DAPI-stained cells, and then the mean value was determined.
Transfection of tumor spheroids
For transfection experiments, tumor spheroids at day 10 in vitro were used. Transient DNA transfection was performed with the cationic liposome reagent Effectene (Qiagen, Hilden, Germany) using 1 µg DNA per 35-mm cell culture dish of pEGFP as control plasmid, pEGFP-antisenseCPP32, and pEGFP-senseBcl-xl following essentially the instructions of the manufacturers. Twentyfour hours after transfection, the medium was changed (RPMI 1640, 10% FCS 50 U/ml penicillin, 50 µg/ml streptomycin). Transfected spheroids did not show any morphological changes compared to untransfected versions. To induce apoptosis, 100 µM end concentration of MTX (Amethopterin; Sigma-Aldrich, Deisenhofen, Germany) was added to the culture dishes 48 h after transfection and further incubated for 24 h. Finally, the spheroids were harvested for determination of caspase-3 expression or alternatively fixed in 4% formaldehyde for the detection of apoptotic cells or used for impedance measurement as described.
Construction of expression vectors pEGFP-CPP32 antisense and pEGFP-Bcl-xl sense
The eukaryotic vector pEGFP-antisenseCPP32 was constructed using pUC18 caspase-3 (Clonexpress, #CE 1003, Biocat, Heidelberg, Germany) as the output vector. Human caspase-3 cDNA (834 bp) was cut out of the vector with EcoRI (3′) and HindIII (5′) and cloned into the linearized pEGFP-N1 reporter gene vector (Clonetech, Palo Alto, CA) in the antisense direction. For the construction of the pEGFP-sense Bcl-xl vector, pSFFV-Bcl-xl (a kind gift from Drs. Gayle Middelton and Gabriel Nunez, Edinburgh, UK) was cut with EcoRI. The exserted 1 kb large fragment of murine flag tagged Bcl-xl was then inserted in the sense direction into the EcoRI site of pEGFP-N1. The cloning procedure was carried out according to standard protocols 27 and sequenced according to a correct reading frame and sequence direction.
Measurement of the impedance spectra using tumor spheroids in capillary sensors
The impedance spectrum of a tumor spheroid was measured according to the principle of Thielecke and others. 7 Briefly, transfected spheroids with the size of 450 to 500 µm, which were untreated or treated with 100 µM of MTX, were chosen. Then, a spheroid was hydrodynamically positioned in a special glass capillary filled with culture medium. An alternating current was applied over electrodes that were implemented into the capillary as a 4electrode arrangement at the ends of the cavity and connected to an impedance analyzer (Solatron SI-1260; Solatron, Farnborough, UK). Thus, the impedance of the tumor spheroid could be measured over a frequency range of 1 to 10 kHz. To compare the different settings of spheroids, the mean values of the impedance spectra of 6 spheroids were calculated. The equivalent circuit model of Thielecke and others 7 was used for fitting the measured impedance data.
Breast Cancer Spheroid Model
RESULTS
MTX influences the expression of caspase-3 in tumor spheroids
In this report, we investigated the effects of MTX on spheres of T-47D clone 11 mamma carcinoma cells. A treatment of tumor spheroids with an increasing concentration of MTX resulted in an increase of caspase-3 protein in these spheres. A basal level of caspase-3 could also be measured in control spheroids (Fig. 1A) . The intensity of the caspase-3 protein bands of the Western blot was determined by a densitometer, whereas the control band was set to 100%. Spheroids treated with 100 µM of MTX showed an increase of the relative caspase-3 level of 40% (Fig. 1B) .
Antisense caspase-3 treatment and Bcl-xl overexpression reduce apoptosis in MTX-treated tumor spheroids
Here we investigated whether alterations in the caspase-3 and Bcl-xl expression level influence the effect of MTX in 3D breast cancer spheroids. In gene-modified tumor spheroids showing any ability for apoptosis according to the decrease of caspase-3 and/or increase of the apoptotic suppressor Bcl-xl, obviously MTX affects the caspase-3 gene expression. In Western blot analysis, various expression levels of caspase-3 protein dependent on MTX concentrations could be detected in transfected and treated tumor spheres ( Fig. 2A) . Regarding the antisense caspase-3cDNA and sense Bcl-xlcDNA transfected spheres, untreated or control spheroids transfected with pEGFP vectors without inserts showed a basal level of caspase-3 protein. Tumor spheroids with caspase-3 suppression or Bcl-xl overexpression versus control spheres showed a reduction of caspase-3 expression of about 46% in caspase-3-antisense-treated and of approximately 59% in Bcl-xltreated spheroids (Fig. 2B ). After incubation of these spheroids with MTX for 24 h, the relative caspase-3 expression of antisense caspase-3cDNA-transfected tumor spheres decreased to 24.1%, and senseBcl-xlcDNA-treated tumor models decreased to 11.9% compared to controls (Fig. 2C) . caspase-3cDNA-or sense Bcl-xlcDNA-transfected tumor models showed only 13% TUNEL-positive cells (Fig. 5B) .
Methotrexate screening in gene-modified, aggressive breast cancer spheres coupled to a capillary
In this study, we investigated the altered molecular events in gene-modified and more aggressive tumor spheres showing a lower tendency to apoptosis for an MTX screening and correlated the data with those of impedance measurements. For each experimental setting, spheroids with a size of approximately 500 µm were identified, and the impedance spectra over a frequency range of 1 Hz to 10 kHz were recorded. Gene-modified tumor spheroids versus controls showed differences in this frequency range (Fig.  6A) . The effective extracellular resistance of the control spheroids (85 kΩ) was smaller than that of antisense caspase-3cDNA-(95 kΩ) or sense Bcl-xlcDNA-transfected (150 kΩ) spheroids (Fig.  6B ). In the same frequency range, the impedance spectra of these spheres after the MTX treatment were different in comparison to control spheroids (Fig. 6C) . The effective extracellular resistance of antisense caspase-3 and sense Bcl-xl-transfected tumor spheroids was 75 kΩ, and that of control spheroids was 52 kΩ (Fig. 6D) .
DISCUSSION
In this report, we demonstrated the development of a more aggressive human breast cancer spheroid as a relevant 3D in vitro tumor model to study aspects of cancer biology (e.g., immortality, telomerase activation, antiapoptotic strategy, etc.). As discussed in various studies, 3D in vitro reconstitutions of tumor cells preserve an important system of simulating in vivo tumor tissues for testing novel anticancer therapies and for generating drugs as well as searching for mechanisms that are responsible for developing multidrug resistances and antiapoptotic strategies. It is known from previous data that the caspase-3 precursor is expressed in different human tumor cell lines and that its processing to an active proteolytic enzyme plays an important role in apoptotic signal pathways. 28, 29 We showed that the antimetabolite MTX treatment of these more aggressive tumor models showing a suppression of caspase-3 and finally a lower level of apoptosis alters the expression of caspase-3 protein to a much lower level and is less successful for anticancer treatment. The proteins of the Bcl-2 family are known physiological antagonists of apoptosis and are able to block cell death induced by different stimuli. 30 The transfection of tumor spheroids with antisense caspase-3cDNA and sense Bcl-xlcDNA expression vectors resulted in an expected downregulation of caspase-3 in MTX-treated as well as in untreated spheroids, whereas the decrease of capase-3 protein in treated spheroids was more intensive than in untreated spheres. A basal level of caspase-3 in control spheroids is present because apoptosis occurs in cancer cells cultured as 3D in vitro spheres, as was described for tumor tissues according to various reports. 10, [31] [32] [33] [34] A parallel determination of apoptotic cells in tumor spheroids showed that the downregulation of caspase-3 correlates with a reduction of apoptosis in MTXtreated spheroids. The results show that the expected effect of MTX to induce the programmed cell death in cells of tumor spheroids could not be observed in our antiapoptotic spheres simulating therapeutical problems of in situ tumors. These data correlate to studies of Fukuoka and Saijo, 35 who reported that apoptosis was inhibited in a Bcl-2-transfected human lung cancer cell line. Regarding the multidrug resistance of tumors against anticancer therapies due to the phenomenon of multicellular resistance, the shown molecular strategy of inhibiting apoptosis induced by a stimulus could be discussed as a possible mechanism of how cancer cells may have developed a protection strategy against special antitumor drugs or treatments. Using an in vitro tumor model, we demonstrated a simulation of an aggressive tumor that may activate cellprotective pathways or inhibit apoptotic pathways according to ex- posure to a cytotoxic agent. Based on such an experimental setting, new therapies and anticancer drugs could be generated that circumvent the development of resistances in tumor cells. To push the approach of tumor research, the use of such gene-modified, more aggressive in vitro tissue models and the design of tissue-based assays for an ultra-fast and specific detection of cellular effects are absolutely required. Over the past few years as well as in recent studies, the advantages of the application of multicellular spheroids are discussed as an ideal basis for high-throughput or much more high-content screening for drugs and their mechanisms and for the evaluation of novel and combinatorial anticancer therapies. 36, 37 Here, we demonstrated not only the development of a more aggressive, antiapoptotic breast cancer tumor model in vitro but also the coupling of this model to a bioelectronic sensor for a real-time monitoring in viable tumor spheres via impedance spectroscopy. By measuring the impedance within a frequency range of 1 Hz to 10 kHz, representing the extracellular resistance of a tissue and therefore reflecting physiological alterations (e.g., proliferation, apoptosis), we successfully determined the cellular effects of the antisense-directed and Bcl-2-triggered downregulation of caspase-3. Furthermore, these impedimetric measurement studies correlated with the molecular data of the MTX exposure on tumor spheroids and verified the MTX-triggered decrease of caspase-3. The decrease of the extracellular resistance of these tumor models in vitro reflects a decrease of the volume fraction and the cellular density per volume of spheres caused by the inhibition of cellular proliferation and/or induction of apoptosis. 7 Our data in this actual report are consistent with the experiences of an anticancer strategy in 3D in vitro tumor models that documented a decrease of cells by inhibition of proliferation, and induction of apoptosis correlated with a decrease of the extracellular resistance. Here, we detected a lower level of apoptosis, although the gene-modified tumor models were treated with the cytotoxic agent MTX and correlate with a higher extracellular resistance in the impedance frequency range from 1 Hz to 10 kHz. This effect could be interpreted as these tumor models having a higher density of cells per volume because the apoptotic level is lower and the survival of cells is higher than in controls.
CONCLUSIONS
As biotechnology demands powerful effective methods with respect to faster drug development and in evaluating novel therapies, we created a tissue model of human mammary carcinoma cells that can be connected to a cell-based electronic sensor system. Establishing these gene-modified 3D in vitro tumor spheroids, a model of a more aggressive tumor tissue to screen drugs and study their effects on cellular mechanisms was created. Through overexpression of the antiapoptotic protein Bcl-xl or suppression of the cell death-mediated caspase-3 enzyme, we were able to manipulate important cellular mechanisms that were responsible for an alteration of the effect of the chemotherapeutic MTX on tumor spheroids. Furthermore, these gene-modified tumor spheres could be combined with a capillary-based sensor system measuring physiological alterations via impedance spectroscopy in correlation to molecular data. Compared to conventional and timeintensive, biochemical assays, the advantage of this technological effort is the fast and noninvasive characterization and real-time monitoring of molecular alterations in tissues due to various stimuli. In the future, this technique could be applied on a multimicrocapillary array that preserves an automated parallel monitoring of the toxicity, metabolism, and absorption of drugs in living tissues. Such a screening system would therefore support the fast and precise development of novel diagnosis and therapeutics.
